Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Looking for quick cash? Explore ways to earn money fast this week and implement strategies to increase your earnings.
17,812 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Tech shares lead a broad market rally as a truce between Iran and the United States reduces geopolitical risk, liftin...
Palantir maintains AI-driven momentum into 2026, but investors weigh continued growth against contracts and policy ri...
Meta is pulling ahead in the AI talent race as policy headwinds tighten, placing Anthropic on the defensive and rattl...
Foreign small-cap value outperformed the S&P 500 by 5.7% in 2026, shaking up the dominance of U.S. stocks and reignit...
SpaceX has landed a historic IPO. This article lays out a 180-day plan for investors, with key dates, valuations, and...
A major shift in early trading set the tone for Accenture's latest results. This article explains why accenture stock...
When a Opendoor director sells a sizable stake, investors wonder if it hints at trouble or simply liquidity needs. Th...
As stock market volatility rages, the S&P 500 sits at a high valuation that history warns could verge on trouble. Thi...
Tech-led optimism lifts the Nasdaq Composite as oil prices retreat. Traders weigh the Fed path and AI earnings signal...
Bitcoin slides to $62K as the broader market weakens, but long bets rise in response, complicating the bitcoin price ...
XRP is hovering around $1.10 with steady buying activity backing a high weekly volume. While the price sits tight, tr...